ACUTE VASCULAR TOXICITY AFTER COMBINATION CHEMOTHERAPY WITH CISPLATIN, VINBLASTINE, AND BLEOMYCIN FOR TESTICULAR CANCER

被引：67
|
作者：
STEFENELLI, T
KUZMITS, R
ULRICH, W
GLOGAR, D
机构：
[1] VIENNA UNIV,DEPT MED 2,A-1090 VIENNA,AUSTRIA
[2] VIENNA UNIV,DEPT PATHOL,A-1090 VIENNA,AUSTRIA
来源：
EUROPEAN HEART JOURNAL | 1988年 / 9卷 / 05期
关键词：
D O I：
10.1093/oxfordjournals.eurheartj.a062542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：552 / 556
页数：5
相关论文
共 50 条
  • [41] 5-YEAR SURVIVAL OF PATIENTS WITH DISSEMINATED NONSEMINOMATOUS TESTICULAR CANCER TREATED WITH CISPLATIN, VINBLASTINE, AND BLEOMYCIN
    STOTER, G
    VENDRIK, CPJ
    STRUYVENBERG, A
    SLEYFER, DT
    VRIESENDORP, R
    KOOPS, HS
    VANOOSTEROM, AT
    HUININK, WWT
    PINEDO, HM
    CANCER, 1984, 54 (08) : 1521 - 1524
  • [42] BLEOMYCIN COMBINATION CHEMOTHERAPY IN MANAGEMENT OF TESTICULAR NEOPLASIA
    SAMUELS, ML
    HOLOYE, PY
    JOHNSON, DE
    CANCER, 1975, 36 (02) : 318 - 326
  • [43] Cis-diamminedichloroplatinum, vinblastine, and bleomyein combination chemotherapy in disseminated testicular cancer
    Einhorn, LH
    Donohue, J
    JOURNAL OF UROLOGY, 2002, 168 (06): : 2368 - 2372
  • [44] LACK OF LATE TOXICITY IN PATIENTS TREATED WITH CISPLATIN-CONTAINING COMBINATION CHEMOTHERAPY FOR METASTATIC TESTICULAR CANCER
    BOYER, M
    RAGHAVAN, D
    HARRIS, PJ
    LIETCH, J
    BLEASEL, A
    WALSH, JC
    ANDERSON, S
    TSANG, CS
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) : 21 - 26
  • [45] EVALUATION OF BLEOMYCIN, ADRIAMYCIN, AND VINBLASTINE IN COMBINATION THERAPY FOR ADVANCED TESTICULAR TUMORS
    KARDINAL, CG
    JACOBS, EM
    BULL, F
    BATEMAN, JR
    PAJAK, T
    CANCER TREATMENT REPORTS, 1976, 60 (07): : 953 - 954
  • [46] CISPLATIN, VINBLASTINE, AND BLEOMYCIN COMBINATION THERAPY IN RESISTANT GESTATIONAL TROPHOBLASTIC DISEASE
    GORDON, AN
    KAVANAGH, JJ
    GERSHENSON, DM
    SAUL, PB
    COPELAND, LJ
    STRINGER, CA
    CANCER, 1986, 58 (07) : 1407 - 1410
  • [47] COMBINATION CHEMOTHERAPY WITH VINBLASTINE, IFOSFAMIDE AND CISPLATIN IN BULKY SEMINOMA
    CLEMM, C
    HARTENSTEIN, R
    WILLICH, N
    LEDDEROSE, G
    WILMANNS, W
    ACTA ONCOLOGICA, 1989, 28 (02) : 231 - 235
  • [48] COMBINATION CHEMOTHERAPY WITH CISPLATIN-VINBLASTINE IN MALIGNANT MESOTHELIOMA
    TSAVARIS, N
    MYLONAKIS, N
    KARVOUNIS, N
    BACOYIANNIS, C
    BRIASOULIS, E
    SKARLOS, D
    PAVLIDIS, N
    STAMATELOS, G
    KOSMIDIS, P
    LUNG CANCER, 1994, 11 (3-4) : 299 - 303
  • [49] VARIABLES FOR PREDICTING SERIOUS TOXICITY (VINBLASTINE DOSE, PERFORMANCE STATUS, AND PRIOR THERAPEUTIC EXPERIENCE) - CHEMOTHERAPY FOR METASTATIC TESTICULAR CANCER WITH CIS-DICHLORODIAMMINEPLATINUM(II), VINBLASTINE, AND BLEOMYCIN
    KRIKORIAN, JG
    DANIELS, JR
    BROWN, BW
    HU, MSJ
    CANCER TREATMENT REPORTS, 1978, 62 (10): : 1455 - 1463
  • [50] CISPLATIN, ETOPOSIDE, IFOSFAMIDE, VINCRISTINE AND BLEOMYCIN COMBINATION CHEMOTHERAPY FOR FAR ADVANCED TESTICULAR-CARCINOMA
    HARSTRICK, A
    SCHMOLL, HJ
    KOHNEWOMPNER, CH
    BERGMANN, L
    LAMMERS, U
    HOHNLOSER, J
    DOLKEN, G
    REICHHARDT, P
    SIEGERT, W
    NATT, F
    RATH, U
    WILKE, H
    POLIWODA, H
    ANNALS OF ONCOLOGY, 1991, 2 (03) : 197 - 202
12345